Bass, Berry & Sims is pleased to announce the release of the newest edition of its Healthcare Fraud & Abuse Annual Review examining important healthcare fraud developments in 2020. Compiled by the firm’s Healthcare Fraud Task Force, the Review provides an in-depth and comprehensive analysis of the past year’s court decisions involving the False Claims Act, settlements involving significant fraud and abuse issues, and enforcement developments affecting the healthcare industry.
When we released last year’s Healthcare Fraud & Abuse Review in early 2020, none of us could have predicted what the year ahead would bring. By March 2020, we saw healthcare professionals standing at the forefront of one of the greatest health crises in a generation, and we saw our healthcare system quickly stressed to the breaking point by the COVID-19 pandemic. Over the next several months, we saw trillions of stimulus dollars distributed by the federal government to provide economic relief to individuals and businesses. By 2020’s end, we saw the beginnings of a massive and historic vaccine rollout designed to stem the continued rising tide of COVID-19 infections against the backdrop of leadership changes at the highest levels of government.
Along the way, we continued to pay close attention to the fraud and abuse issues facing the healthcare industry. Our Healthcare Fraud & Abuse Review covers these issues and looks ahead to the challenges likely to come for healthcare providers facing the prospect of increased government scrutiny, whistleblower lawsuits under the False Claims Act, and government regulators pursuing civil and criminal healthcare fraud enforcement.
This year’s Healthcare Fraud & Abuse Review examines:
- Issues for the healthcare industry to watch in 2021.
- Enforcement implications of the Coronavirus Aid, Relief, and Economic Security (CARES) Act /COVID-19 relief.
- Noteworthy False Claims Act settlements from 2020.
- Comprehensive coverage of significant False Claims Act decisions.
- Notable developments involving the Stark Law and Anti-Kickback Statute.
- Enforcement developments impacting the pharmaceutical and medical device industries.